This page shows the latest Abraxane news and features for those working in and with pharma, biotech and healthcare.
11.1 months compared to 9.2 months for patients treated with the standard regimen of Bristol-Myers Squibb’s Abraxane (nab-paclitaxel) plus gemcitabine.
Tecentriq has already been approved in combination with Abraxane (nab-paclitaxel), after demonstrating a statistically significant PFS benefit and clinically meaningful improvements in OS for people with metastatic TNBC whose tumours
In December, Roche also won approval for Tecentriq in combination with a chemotherapy regimen of Abraxane and carboplatin in NSCLC patients, whose cancer has metastasized and does not have EGFR or
The actual progression-free survival (PFS) numbers for KEYNOTE-355 – which compared Keytruda plus Bristol-Myers Squibb/Celgene’s Abraxane (nab-paclitaxel), paclitaxel or gemcitabine/carboplatin to the chemo drugs given ... plus Abraxane.
Tecentriq has been approved by the EMA for use in patients ineligible for surgery alongside Celgene’s Abraxane (nab-paclitaxel), and NICE estimates that around 600 of the 2, 000 women
The scale of those revenues will very much depend on how far Roche can extend its use beyond this first setting in combination with Abraxane. ... Oncologists say there is still debate about what the best chemotherapy backbone is for anti-PD-L1 treatment
More from news
Approximately 14 fully matching, plus 40 partially matching documents found.
An FDA ruling on Tecentriq in combination with carboplatin and nab-paclitaxel (Abraxane) as a first-line treatment for patients with metastatic non-squamous NSCLC (based on the IMpower130 trial) is
Meanwhile, BeiGene entered into a strategic global collaboration with Celgene in 2017, gaining the rights to Celgene’s Abraxane Revlimid and Vidaza in China, while Celgene gained an option to market
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
cells. A good example of this is the combined use of Abraxane and gemcitabine in the treatment of metastatic adenocarcinoma of the pancreas – Abraxane helps to inhibit cancer cell growth, and
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...